Holen Sie sich die Stockscreener-App
0.1005
5.68%
0.0054
Schlusskurs vom Vortag:
$0.0951
Offen:
$0.117
24-Stunden-Volumen:
8.44M
Relative Volume:
7.92
Marktkapitalisierung:
$121.14K
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-94.65%
1M Leistung:
-98.10%
6M Leistung:
-99.97%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.0931
$0.2089
1-Wochen-Bereich:
$0.085
$1.86
52-Wochen-Spanne:
$0.085
$17,908.00
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Firmenname
Cero Therapeutics Holdings Inc
Sektor
Branche
Telefon
650-407-2376
Adresse
201 HASKINS WAY, SOUTH SAN FRANCISCO
Vergleichen Sie CERO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
0.1005 | 177.38K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Hochstufung | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Aktie (CERO) Neueste Nachrichten
Using fundamentals and technicals on CERo Therapeutics Holdings Inc. Equity WarrantOil Prices & Risk Managed Investment Signals - newser.com
CERo Therapeutics (OTC: CERO) to show CER-1236 sustained expansion, cytokine response at SITC - Stock Titan
Real time breakdown of CERo Therapeutics Holdings Inc. Equity Warrant stock performanceWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
CERo Therapeutics Holdings Inc. Equity Warrant stock trendline breakdownM&A Rumor & Safe Capital Growth Stock Tips - newser.com
Multi asset correlation models including CERo Therapeutics Holdings Inc. Equity WarrantJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Why CERo Therapeutics Holdings Inc. stock is considered a top pickGold Moves & Safe Capital Allocation Plans - newser.com
Can CERo Therapeutics Holdings Inc. hit a new high this monthJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Is CERo Therapeutics Holdings Inc. still worth holding after the dipQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
Published on: 2025-11-04 01:19:45 - newser.com
What recovery options are there for CERo Therapeutics Holdings Inc.July 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
How CERo Therapeutics Holdings Inc. Equity Warrant stock reacts to job market dataMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
Short interest data insights for CERo Therapeutics Holdings Inc. Equity Warrant2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
What machine learning models say about CERo Therapeutics Holdings Inc.Earnings Risk Summary & Reliable Price Breakout Signals - newser.com
Why CERo Therapeutics Holdings Inc. stock is rated strong buyWeekly Investment Summary & Growth Oriented Trade Recommendations - newser.com
CERO Downgraded to Hold by Maxim Group | CERO Stock News - GuruFocus
CERO SEC FilingsCERo Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Why CERo Therapeutics Holdings Inc. Equity Warrant stock remains on buy listsWeekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Is it too late to sell CERo Therapeutics Holdings Inc.July 2025 Highlights & Reliable Breakout Forecasts - newser.com
CERo Therapeutics Announces Listing on OTC Markets - The Manila Times
Evaluating CERo Therapeutics Holdings Inc. with trendline analysisMarket Movement Recap & Community Driven Trade Alerts - newser.com
What Fibonacci levels say about CERo Therapeutics Holdings Inc. reboundMarket Risk Summary & Daily Profit Focused Screening - newser.com
CERo Therapeutics (OTC PINK: CERO) lists on OTC Pink, exploring uplist options - Stock Titan
Why CERo Therapeutics Holdings Inc. stock is popular among millennialsQuarterly Earnings Summary & Precise Buy Zone Identification - newser.com
Why CERo Therapeutics Holdings Inc. Equity Warrant stock attracts global investors2025 Price Action Summary & Community Driven Trade Alerts - newser.com
How institutional ownership impacts CERo Therapeutics Holdings Inc. Equity Warrant stock2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-03 04:57:07 - newser.com
How CERo Therapeutics Holdings Inc. Equity Warrant stock trades before earningsEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Can CERo Therapeutics Holdings Inc. stock weather global recessionWeekly Trade Recap & Verified Momentum Watchlists - newser.com
What momentum shifts mean for CERo Therapeutics Holdings Inc.July 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
Will CERo Therapeutics Holdings Inc. stock recover faster than marketQuarterly Profit Review & Daily Oversold Bounce Ideas - newser.com
Applying Elliott Wave Theory to CERo Therapeutics Holdings Inc.Bull Run & Reliable Volume Spike Trade Alerts - newser.com
Using flow based indicators on CERo Therapeutics Holdings Inc.Earnings Growth Summary & Accurate Entry/Exit Alerts - newser.com
How moving averages guide CERo Therapeutics Holdings Inc. tradingQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Published on: 2025-11-03 00:15:03 - newser.com
Can CERo Therapeutics Holdings Inc. Equity Warrant stock attract ESG capital inflowsBull Run & Real-Time Chart Breakout Alerts - newser.com
Can a trend reversal in CERo Therapeutics Holdings Inc. lead to recoveryJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com
Leading vs lagging indicators on CERo Therapeutics Holdings Inc. Equity Warrant performanceTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Is CERo Therapeutics Holdings Inc. Equity Warrant stock attractive for income investorsJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Using RSI to spot recovery in CERo Therapeutics Holdings Inc. Equity Warrant2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Identifying reversal signals in CERo Therapeutics Holdings Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com
Tools to assess CERo Therapeutics Holdings Inc.’s risk profileQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Analyzing recovery setups for CERo Therapeutics Holdings Inc. investorsJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
Can swing trading help recover from CERo Therapeutics Holdings Inc. lossesMarket Activity Report & Entry Point Confirmation Signals - newser.com
Finanzdaten der Cero Therapeutics Holdings Inc-Aktie (CERO)
Es liegen keine Finanzdaten für Cero Therapeutics Holdings Inc (CERO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Cero Therapeutics Holdings Inc-Aktie (CERO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| YK Bioventures Opportunities G | 10% Owner |
Dec 13 '24 |
Sale |
0.06 |
2,998,908 |
179,934 |
13,005,169 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 12 '24 |
Sale |
0.07 |
1,614,541 |
113,018 |
16,004,077 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 11 '24 |
Sale |
0.08 |
1,343,801 |
107,504 |
17,618,618 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 06 '24 |
Sale |
0.12 |
1,236,874 |
148,425 |
21,383,909 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 10 '24 |
Sale |
0.09 |
1,570,947 |
141,385 |
18,962,419 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 09 '24 |
Sale |
0.11 |
850,543 |
93,560 |
20,533,366 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):